From USFDA
Strides Shasun announced that it has received tentative approval from the USFDA for Roflumilast Tablets, 500 mcg. The product received approval in 15 months under the new GDUFA goal date regime. The product can be launched earliest by January 2020.Powered by Capital Market - Live News